Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

RxSight (RXST) Accumulated Depreciation & Amortization (2020 - 2025)

RxSight (RXST) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 8.33% year-over-year to $3.3 million, compared with a TTM value of $3.3 million through Dec 2025, down 8.33%, and an annual FY2025 reading of $3.3 million, down 8.33% over the prior year.
  • Accumulated Depreciation & Amortization was $3.3 million for Q4 2025 at RxSight, down from $3.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.1 million in Q4 2023 and bottomed at $3.3 million in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.8 million, with a median of $3.9 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 5.13% in 2023, then dropped 12.2% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $4.0 million in 2021, then fell by 2.5% to $3.9 million in 2022, then rose by 5.13% to $4.1 million in 2023, then decreased by 12.2% to $3.6 million in 2024, then decreased by 8.33% to $3.3 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for RXST at $3.3 million in Q4 2025, $3.6 million in Q4 2024, and $4.1 million in Q4 2023.